Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] (2021)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; OSORIO, FLAVIA DE LIMA - FMRP ; CAMPOS, ALLINE CRISTINA DE - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; PACHECO, JÚLIA COZAR - FMRP ; SOUZA, JOSÉ DIOGO DOS SANTOS - FMRP
- Unidade: FMRP
- DOI: 10.1097/JCP.0000000000001405
- Subjects: CANABINOIDES; ANTICONVULSIVANTES; COVID-19; ESTRESSE PROFISSIONAL; SAÚDE MENTAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2021
- Source:
- Título: Journal of Clinical Psychopharmacology
- ISSN: 0271-0749
- Volume/Número/Paginação/Ano: v. 41, n. 3, p. 327-329, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PACHECO, Júlia Cozar et al. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/JCP.0000000000001405. Acesso em: 23 jan. 2026. , 2021 -
APA
Pacheco, J. C., Souza, J. D. dos S., Hallak, J. E. C., Osório, F. de L., Campos, A. C. de, Guimarães, F. S., et al. (2021). Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/JCP.0000000000001405 -
NLM
Pacheco JC, Souza JD dos S, Hallak JEC, Osório F de L, Campos AC de, Guimarães FS, Zuardi AW, Crippa JA de S. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 327-329.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1097/JCP.0000000000001405 -
Vancouver
Pacheco JC, Souza JD dos S, Hallak JEC, Osório F de L, Campos AC de, Guimarães FS, Zuardi AW, Crippa JA de S. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 327-329.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1097/JCP.0000000000001405 - Case report: cannabidiol-induced skin rash: a case series and key recommendations
- The anxiolytic effects of cannabidiol (CBD)
- Cannabinoids for the treatment of mental disorders [Carta]
- Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
- Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022)
- Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
Informações sobre o DOI: 10.1097/JCP.0000000000001405 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
